Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

P3 Health Partners Inc

Healthcare US PIII

10.77USD
0.72(7.16%)

Last update at 2026-06-04T17:51:00Z

Day Range

9.8711.27
LowHigh

52 Week Range

0.445.56
LowHigh

Fundamentals

  • Previous Close 10.05
  • Market Cap313.25M
  • Volume92353
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-76.27000M
  • Revenue TTM1352.79M
  • Revenue Per Share TTM11.84
  • Gross Profit TTM -7.75300M
  • Diluted EPS TTM-0.52

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -31411.54200M - -45.38158M -41.97156M -49.77401M
Minority interest 1291.43M - 4.31M 7.91M 5.97M
Net income -10.08100M - -31.41154M -41.97156M -43.80130M
Selling general administrative 53390.34M - 53.39M 36.42M 28.54M
Selling and marketing expenses 1502.63M - 1.50M 0.80M 1.87M
Gross profit 491063.53M - 485.54M 145.48M 87.70M
Reconciled depreciation 87.29M - 0.80M 0.40M 0.34M
Ebit -155.88729M -187.94600M -35.12063M -39.43772M -49.71451M
Ebitda -31411.54200M - -34.32546M -39.03854M -49.37232M
Depreciation and amortization 0.09M - 0.80M 0.40M 0.34M
Non operating income net other - - - - -
Operating income -31411.54200M - -35.12063M -39.53567M -49.71451M
Other operating expenses 519651.20M 37.84M 520.66M 185.02M 137.41M
Interest expense 2533.18M - 9.97M 2.53M 0.04M
Tax provision 1.86M - - 0.00000M -
Interest income - - - - -
Net interest income -11.40400M - -9.97026M -3.47914M 0.04M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -31401.46100M - -3.99977M 2.63M -6.01695M
Total revenue 491063.53M - 485.54M 145.48M 87.70M
Total operating expenses 519651.20M - 520.66M 185.02M 137.41M
Cost of revenue - - - - -
Total other income expense net -1302.30000M - -0.29068M 0.10M -0.10373M
Discontinued operations - - - - -
Net income from continuing ops -1561.55700M - -45.38158M -42.91685M -49.77401M
Net income applicable to common shares -270.12700M -10.08100M -41.07451M -35.00926M -
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 860.97M 2364.11M 2364.11M 99.90M 65.61M
Intangible assets 666.73M 835.84M 835.84M - -
Earning assets - - - - -
Other current assets 3.61M 57566.36M 7.32M 8.83M 1.35M
Total liab 427.31M 299.94M 299.94M 145.96M 73.98M
Total stockholder equity 142.13M 273.55M 273.55M -27.86545M 5.50M
Deferred long term liab - - - - -
Other current liab 62.31M 177.42M 177.42M 78.73M 20.54M
Common stock 0.03M 0.02M 0.02M 97.19M 89.75M
Capital stock 0.03M 0.02M 0.02M 45.58M 42.19M
Retained earnings -367.34400M -39.41812M -39.41812M -126.24223M -85.16772M
Other liab - - 14.87M 51.61M 47.56M
Good will - 1309.75M 1309.75M 0.87M 0.74M
Other assets - 4.29M 3.59M 3.80M 3.70M
Cash 40.93M 140.48M 140.48M 36.26M 32.59M
Cash and equivalents - - - - -
Total current liabilities 299.37M 198.77M 198.77M 90.62M 54.57M
Current deferred revenue 12.70M - - - 28.72M
Net debt 83.71M -50.55604M -50.55604M 12.85M -11.55716M
Short term debt 2.70M 3.62M 3.62M 0.09M 1.63M
Short long term debt - - 3.62M 0.09M 1.63M
Short long term debt total 124.64M 89.92M 89.92M 49.11M 21.04M
Other stockholder equity 509.44M 312.95M - 1.19M 0.92M
Property plant equipment - 20.54M 15.07M 8.08M 7.70M
Total current assets 166.02M 199.86M 199.86M 84.35M 52.35M
Long term investments - - - - -
Net tangible assets - - -1872.03738M -86.95474M -44.33765M
Short term investments - - - - -
Net receivables 121.47M 52.07M 52.07M 39.25M 18.42M
Long term debt 108.32M 94.42M 80.00M 45.39M 15.00M
Inventory - -57559.04165M - - -
Accounts payable 221.66M 17.73M 17.73M 11.79M 3.69M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.00000M - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 4.23M 3.59M 3.59M 3.80M 3.70M
Deferred long term asset charges - - - - -
Non current assets total 694.95M 2164.25M 2164.25M 15.55M 13.25M
Capital lease obligations 13.62M 11.52M 6.30M 3.63M 4.41M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -7.73300M - -3.16615M -3.85672M -4.59891M
Change to liabilities 0.00000M 41.96M 8.10M 0.80M -
Total cashflows from investing activities - -56.06500M -3.16615M -3.85672M -
Net borrowings - 28.53M 34.94M 16.63M -
Total cash from financing activities 34760.06M 223.47M 34.76M 63.62M 33.25M
Change to operating activities - 33.82M 24.88M 6.84M -
Net income -31411.54200M -156.48100M -45.38158M -41.97156M -49.77401M
Change in cash 6998.10M 100.93M 7.00M 31.48M -0.58507M
Begin period cash flow 32904.85M 39.90M 32.90M 1.43M 2.01M
End period cash flow 39902.95M 39.90M 39.90M 32.90M 1.43M
Total cash from operating activities -24595.81400M -66.47100M -24.59581M -28.28651M -29.23624M
Issuance of capital stock 0.00000M - - 62.04M -
Depreciation 795.17M 8.72M 0.80M 0.40M 0.34M
Other cashflows from investing activities - 0.21M -0.10953M -2.40486M -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 139.21M 0.45M 0.14M 0.42M -1.38320M
Sale purchase of stock - - - - -
Other cashflows from financing activities 34760.06M -0.37500M 36.25M 16.16M -4.59891M
Change to netincome 22.00M 51.56M -17.66638M -1.74520M -
Capital expenditures 2926.62M 3.41M 2.93M 1.45M 3.31M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 8241.88M - 33.12M 8.07M 4.34M
Stock based compensation 447.48M - 0.45M 0.47M 0.45M
Other non cash items 5573.08M - 6.96M -1.62060M 15.41M
Free cash flow -27522.43500M - -27.52244M -29.73837M -32.54488M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PIII
P3 Health Partners Inc		 0.72 7.16% 10.77 - - 0.24 0.49 0.12 -1.9099
HCA
HCA Healthcare, Inc.		 -1.325 0.36% 361.90 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.18 1.71% 10.68 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 - -% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

P3 Health Partners Inc

2370 Corporate Circle, Henderson, NV, United States, 89074

Key Executives

Name Title Year Born
Dr. Sherif Abdou F.A.C.E.P., FACP, M.D. Co-Founder, CEO & Director 1960
Dr. Amir Bacchus M.B.A., M.D. Co-Founder, Chief Medical Officer & Director 1965
Mr. Atul Kavthekar Chief Financial Officer NA
Ms. Lorie Glisson CPA Exec. Vice Chairwoman, COO & Florida Market Pres NA
Ms. Erin Darakjian Sr. VP & Chief Accounting Officer NA
Mr. Devery Goodey Sr. VP of Technology NA
Ms. Karen Blomquist VP of Investor Relations NA
Ms. Jessica Puathasnanon Chief Legal Officer, Gen. Counsel & Sec. NA
Ms. Cheyenne Ross VP of Compliance NA
Ms. Kassi Belz APR Exec. VP of Communications, Culture & Engagement NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.